Delayed-Onset Glaucoma Following Intravitreal Bevacizumab in a Preterm Infant with Retinopathy of Prematurity: A Case Report. [PDF]
Jang HJ, Sung MS, Park SW, Heo H.
europepmc +1 more source
Innovative Use of Nanomaterials in Treating Retinopathy of Prematurity. [PDF]
Wu KY, Wang XC, Anderson M, Tran SD.
europepmc +1 more source
Postnatal growth and metabolic blood biomarkers in preterm infants developing reversible retinopathy of prematurity. [PDF]
Olsen DA+6 more
europepmc +1 more source
Refractive error in preterm infants without retinopathy of prematurity aged 1-18 months: A propensity score matching analysis. [PDF]
Huo L, Jia X, Li C.
europepmc +1 more source
Association of the ADRB2 rs1042714 variant with retinopathy of prematurity highlights the importance of the renin-angiotensin-aldosterone system. [PDF]
Chmielarz-Czarnocińska A+5 more
europepmc +1 more source
Effect and factors associated with reactivation after intravitreal conbercept or aflibercept in retinopathy of prematurity. [PDF]
Huang C+10 more
europepmc +1 more source
Retinopathy of Prematurity [PDF]
Retinopathy of prematurity (ROP) occurs due to abnormal proliferation of retinal vessels. The most important risk factors which predispose to development of ROP include oxygen therapy, anemia needing blood transfusion, sepsis and apnea. Very low birth weight neonates, those born at ≤ 32 week of gestation and other preterm neonates with risk factors ...
Ashok K. Deorari+5 more
+7 more sources
Related searches:
Retinopathy of Prematurity: A Global Perspective and Recent Developments.
Pediatrics, 2022Retinopathy of prematurity (ROP) is a significant cause of potentially preventable blindness in preterm infants worldwide. It is a disease caused by abnormal retinal vascularization that, if not detected and treated in a timely manner, can lead to ...
K. Sabri+4 more
semanticscholar +1 more source